Dhingra Ankur

Average Profitability
6.03%
Insider Buys Quantity
5
Insider Buys Sum
$873,682.05
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Dhingra Ankur

According to the SEC Form 4 filings, Dhingra Ankur, being in a position of

  1. Chief Financial Officer at Summit Therapeutics Inc.,
    оver the last 12 months, has bought 120400 shares for $419,254, and sold 0 shares,
    over all time since 2022-08-16, has bought 354447 shares for $661,989, and sold 0 shares.

The largest purchase of all time was on 2024-03-26 and amounted to 100000 shares of Summit Therapeutics Inc. for $375,000.

Biography of Dhingra Ankur

No biography is available at this moment.

2024-03-26PurchaseSummit Therapeutics Inc.
SMMT
Chief Financial Officer
100,000
0.0143%
$3.75$375,000+160.7%
2023-12-13PurchaseSummit Therapeutics Inc.
SMMT
Chief Financial Officer
20,400
0.0027%
$2.17$44,254+98.72%
2023-03-07PurchaseSummit Therapeutics Inc.
SMMT
Chief Financial Officer
196,362
0.0395%
$1.05$206,180+39.49%
2022-08-16PurchaseSummit Therapeutics Inc.
SMMT
Chief Financial Officer
37,685
0.0244%
$0.97$36,554+70.3%
2021-11-24PurchaseCareDx, Inc
CDNA
Chief Financial Officer
5,000
0.0091%
$42.34$211,694-42.84%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.